Shares of Arecor Therapeutics plc (LON:AREC – Get Free Report) hit a new 52-week low during trading on Thursday . The stock traded as low as GBX 90 ($1.17) and last traded at GBX 93 ($1.21), with a volume of 8991 shares. The stock had previously closed at GBX 94.50 ($1.23).
Arecor Therapeutics Stock Down 1.6 %
The firm has a market cap of £28.49 million, a P/E ratio of -506.65 and a beta of -0.21. The company has a debt-to-equity ratio of 3.55, a quick ratio of 6.24 and a current ratio of 2.17. The firm’s fifty day moving average is GBX 131.63 and its 200 day moving average is GBX 143.22.
About Arecor Therapeutics
Arecor Therapeutics plc, a biopharmaceutical company, focuses on developing products in diabetes and other indications. The company through its proprietary formulation technology platform, Arestat, developing a portfolio of proprietary products in diabetes and other indications, as well as working with pharmaceutical and biotechnology companies to deliver enhanced reformulations of therapeutic products.
Featured Stories
- Five stocks we like better than Arecor Therapeutics
- What is the FTSE 100 index?
- This Cybersecurity Stock Gains Analysts’ Favor for Strong Growth
- Technology Stocks Explained: Here’s What to Know About Tech
- Parabolic Rise of This Stock Shows No Signs of Slowing
- What is a Death Cross in Stocks?
- Risk Tolerance vs. Risk Appetite: Key Differences
Receive News & Ratings for Arecor Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arecor Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
